Quinidine☆
-
Add time:09/03/2019 Source:sciencedirect.com
Quinidine is the d-isomer of quinine. Quinidine is an important class Ia antiarrhythmic drug. It is among the few effective drugs in Brugada Syndrome and in Short QT Syndrome. Recent evidence suggests that it could also be useful in a few non cardiological conditions including pseudobulbar affect and migrating partial seizures of infancy. Quinidine blocks voltage-gated sodium channels in a use- and state-dependent manner. It also acts on several classes of voltage gated K+ channels including delayed rectifiers and KCNT1 channels. The main adverse effects of quinidine are cardiovascular and include torsade des points and hypotension. Quinidine also causes gastrointestinal disturbances and has been associated to immunological complications including thrombocytopenia and a lupus-like syndrome. Acute poisoning with quinidine, also known as cinchonism, has a typical clinical presentation with flushing, sweating, gastrointestinal symptoms blurred vision, diplopia, altered color perception, tinnitus, decreased auditory acuity and vertigo. At higher quinidine concentrations neurological and cardiovascular effects become prevalent.
We also recommend Trading Suppliers and Manufacturers of phenobarbital quinidine (cas 1400-48-2). Pls Click Website Link as below: cas 1400-48-2 suppliers
Prev:ReviewQuinidine—A legacy within the modern era of antiarrhythmic therapy
Next:Quinidine) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research ArticlesIdentification of Complexes of Phenobarbital with Quinine, Quinidine, or Hydroquinidine in Pharmaceutical Dosage Forms09/07/2019
- Selected topics: ToxicologyAre one or two dangerous? Quinine and quinidine exposure in toddlers09/06/2019
- [11C]quinidine and [11C]laniquidar PET imaging in a chronic rodent epilepsy model: Impact of epilepsy and drug-responsiveness☆09/05/2019
- Quinidine09/04/2019
- ReviewQuinidine—A legacy within the modern era of antiarrhythmic therapy09/02/2019
- Case reportConcurrent Quinidine and Phenobarbital in the Treatment of a Patient with 2 KCNT1 Mutations09/01/2019
-
Health and Chemical more >


